Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Queiroz, D. M. M. Articles by Nogueira, A. M. M. F. Search for Related Content PubMed PubMed Citation Articles by Queiroz, D. M. M. Articles by Nogueira, A. M. M. F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, August 2002, p. 2849-2853, Vol. 40, No. 8
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.8.2849-2853.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Role of Corpus Gastritis and cagA-Positive Helicobacter pylori Infection in Reflux Esophagitis

Dulciene Maria Magalhães Queiroz,^1* Gifone Aguiar Rocha,¹ Celso Affonso de Oliveira,¹ Andreia Maria Camargos Rocha,¹ Adriana Santos,¹ Mônica Maria Demas Álvares Cabral,² and Ana Margarida Miguel Ferreira Nogueira²

Laboratory of Research in Bacteriology,¹ Department of Pathology, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil²

Received 5 February 2002/ Returned for modification 7 April 2002/ Accepted 18 May 2002

Top Abstract Introduction Materials and Methods Results Discussion References

 
Considering that the role of Helicobacter pylori infection in gastroesophageal reflux and reflux esophagitis (GERD) is still controversial and that the role of virulence markers of the bacterium has not been evaluated in most studies of GERD, we investigated the association among H. pylori infection with cagA-positive and -negative strains, corpus gastritis, and GERD in a large group of patients by controlling for confounding factors. We studied prospectively 281 consecutive adult patients: 93 with GERD and 188 controls. H. pylori infection status was diagnosed by culture, by the preformed urease test, with a carbolfuchsin-stained smear, and by histology. The cagA status was determined by PCR of H. pylori isolates and gastric biopsy specimens. H. pylori infection was diagnosed in 191 (68.0%) of 281 patients. Among the 93 patients with GERD, 84 presented with mild or moderate esophagitis and 9 presented with severe esophagitis. In the multivariate analysis, the age of the patients and the degree of oxyntic gastritis were associated with GERD. Among the strains isolated from patients with GERD and from the control group, 24.4 and 66.9%, respectively, were positive for cagA (P < 0.001). Compared to infection with cagA-negative strains, infection with cagA-positive H. pylori strains was associated with a more intense gastritis in the corpus (P = 0.001). cagA status (odds ratio [OR] = 0.16, 95% confidence interval [CI] = 0.07 to 0.40), gastritis of the corpus (OR = 0.69, 95% CI = 0.48 to 0.99), and age (OR = 1.04, 95% CI = 1.01 to 1.07) were associated with GERD. In conclusion, the study provides evidence supporting the independent protective roles of cagA-positive H. pylori strains and the degree of corpus gastritis against GERD.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Helicobacter pylori infection is probably one of the most common chronic bacterial infections worldwide. The infection is predominantly acquired in childhood, and in most subjects it runs its course without complications. Nevertheless, a small percentage of infected individuals develop peptic ulcer disease (17), distal gastric carcinoma (19), or mucosa-associated lymphoid tissue lymphoma (28).

Chronic gastroesophageal reflux and reflux esophagitis (GERD) are considered peptic diseases. In recent decades, while the prevalence of H. pylori infection has been declining, the incidence of GERD has been increasing in developed countries (7). Case-control studies (9, 11, 14) have shown that the eradication of H. pylori from patients with duodenal ulcers may provoke GERD. This finding, however, has not been confirmed by other investigators (23, 24). Conflicting data have been also observed in studies evaluating the association between GERD and H. pylori infection. In some of the studies, the rates of H. pylori infection were lower in patients with GERD than in control populations (13, 27, 29), whereas in other studies the prevalence of H. pylori infection was similar (18, 23) or even higher (15) in patients with GERD. However, the small number of subjects, inconsistent methods of determination of H. pylori infection status, or the absence of controls for confounding factors such as age and gender weaken the results of most of these studies and reinforce the need for additional, more controlled evaluations of this subject. Furthermore, the discrepant results may be due to differences among populations as well as overlaps between groups of H. pylori-positive patients colonized by strains lacking and not lacking virulence markers.

Among the putative bacterial virulence factors, the cagA gene, which has been shown to encode a highly immunogenic protein (CagA), is a marker of the cag pathogenicity island (PAI) (2). Patients colonized by strains containing the cag PAI present with more severe gastric inflammation (1, 22), which may explain the lower levels of acid output and the lower levels of protection against GERD. In fact, studies associating the virulence factors of the bacterium with protection against more severe or complicated lesions of GERD such as distal esophageal carcinoma and Barrett's esophagus have been published (3, 10, 25). It must be emphasized that the role of cagA status in offering protection against less severe forms of GERD was not evaluated or demonstrated in the previous studies. Recently, Warburton-Timms et al. (23) have shown in a well-controlled trial a negative association between cagA status and GERD without complications, but they did not investigate the role of corpus gastritis.

Therefore, considering that there is no consensus regarding the role of H. pylori infection in protecting against GERD and that the role of virulence markers of the bacterium have not been evaluated in most studies, our aim was to investigate the association among H. pylori infection, the presence of cagA-positive and -negative strains, the degree of corpus gastritis, and GERD (especially without complications) in a large group of patients by controlling for confounding factors.

Top Abstract Introduction Materials and Methods Results Discussion References

 
This study was approved by the Ethics Committee of the Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. All patients provided informed consent to participate in the study.

From 1997 to 2000 we studied prospectively 281 consecutive adult patients (117 men and 164 women; mean age, 45.0 ± 15.2 years; age range, 18 to 88 years) who were selected from among those who came to the Gastroduodenoscopy Service of Celso Affonso de Oliveira or at the Gastrointestinal Service of the University Hospital—UFMG to clarify the origins of symptoms referable to the upper gastrointestinal tract. All patients with peptic ulcer, esophageal carcinoma, gastric carcinoma, coagulation disorders, complications such as gastric perforation or hemorrhage, anatomic obstacles preventing endoscopy, or esophageal varices and patients who had already undergone gastric surgery were excluded from the study. None of the patients had received antimicrobial drugs, H₂-receptor antagonists, acid pump inhibitors, or nonsteroidal anti-inflammatory drugs for at least 30 days before the study.

The GERD group consisted of patients with endoscopically proven esophagitis with or without hiatal hernia. Patients from the control group did not have hiatal hernia, symptoms of reflux, esophagitis at endoscopy, or abnormalities upon histologic examination of the esophageal mucosa.

The patients were considered H. pylori positive if the culture of the biopsy specimen was positive or if they were positive by two of the following tests: the preformed urease test, carbolfuchsin-stained smear examination, or examination of a histologic section. The patients were considered H. pylori negative if the results of all tests were negative.

Endoscopy. At endoscopy, biopsy specimens were obtained from the antral and oxyntic gastric mucosae for microbiologic, histologic, and molecular analyses and from the esophageal mucosa for histologic study. Esophagitis was classified as mild (presence of enanthema, edema, or friability), moderate (presence of linear, multiple, or confluent erosions), and severe or complicated (presence of ulcers, strictures, or Barrett's metaplasia).

Microbiologic study. Tissue samples for culture were maintained in sodium thioglycolate broth (Difco, Detroit, Mich.) at 4°C for a maximum of 1 h, ground separately in a tissue homogeneizer (Kontes, Vineland, N.J.), and plated onto petri dishes containing fresh Belo Horizonte medium (21). The plates were incubated at 37°C in a microaerophilic atmosphere obtained by use of a gas generation system (Anaerocult C; Merck, Darmstadt, Germany). The plates were evaluated after 3, 6, 9, and 12 days of incubation. Strains with macroscopic and microscopic morphologies typical of H. pylori, rapidly positive by a urease test, positive by oxidase and catalase reactions, and found to contain ureA were identified as H. pylori. A pool of strains of the microorganism(s) from each patient was maintained at -80°C in brucella broth supplemented with 30% glycerol.

One antral fragment was placed in a tube containing Christensen's 2% urea agar, and the tube was examined within 24 h of incubation at 37°C for urea hydrolysis.

One antral biopsy specimen was immediately rubbed on a glass slide and subsequently heat fixed and stained with 40% carbolfuchisin for detection of spiral-shaped bacteria.

PCR analysis. All H. pylori strains, as well as gastric fragments from H. pylori-positive patients from whom the microorganism was not isolated, were evaluated for the presence of cagA and ureA. Two cagA-positive strains (strains ATCC 49503 and NCTC 11637) and one cagA-negative strain (strain Tx 30A) were used as positive and negative controls, respectively, for cagA detection. The same H. pylori strains and two human isolates (Proteus mirabilis and Escherichia coli) were used as positive and negative controls, respectively, in the reaction for ureA detection. A reagent-negative control reaction, in which DNA samples were replaced with distilled water, was done with each batch of amplification to exclude contamination.

The H. pylori strains were thawed, plated onto brain heart infusion agar plates supplemented with 10% sheep blood, and incubated at 37°C under microaerophilic conditions for 3 days. Abundant bacterial growth on a petri dish (diameter, 60 mm) was transferred with a sterile swab to a tube containing 1 ml of phosphate-buffered saline (PBS; pH 7.4).

Tissue or bacterial DNA was suspended in a tube containing 1 ml of PBS; the tube was centrifuged twice at 13,000 x g for 10 min each time; and the contents of the tube were suspended in a buffer containing 8% sucrose, 50 mM Tris HCl (pH 8.0), 50 mM EDTA, and 0.1% Triton X-100. Lysozyme from chicken egg white (Boehringer Mannheim, Indianapolis, Ind.) was added to a final concentration of 3 mg/ml, and the solution was incubated for 12 min at 37°C. Sodium dodecyl sulfate and RNase from bovine pancreas (Boehringer Mannheim, Mannheim, Germany) were added to final concentrations of 0.8 and 0.5 mg/ml, respectively, and the samples were incubated overnight at 37°C in a 5% (wt/vol) cetyltrimetylammonium bromide (CTAB; Sigma, St. Louis, Mo.)- 0.7 M NaCl solution (1:10) was added, and the solution was gently mixed and incubated at 55°C for 10 min. The DNA was extracted with equal volumes of phenol and chloroform (1:1) and was precipitated overnight at -20°C in the presence of 0.3 M sodium acetate and 3.1 volumes of absolute ethanol. The DNA precipitates were then pelleted by centrifugation at 16,000 x g for 30 min and allowed to air dry. The pellets were suspended in sterile distilled water, and the DNA was quantified by measuring the optical density at 260 nm.

Genomic DNA was amplified by PCR for the detection of cagA by using two sets of synthetic oligonucleotides primers, as described elsewhere by Kelly et al. (12) and Peek et al. (20). The amplified PCR products were resolved in 1% agarose gels containing Tris-borate-EDTA by using a 100-bp molecular size marker (Gibco BRL, Gaithersburg, Md.). The agarose gels were stained with ethidium bromide and viewed under short-wavelength UV light. The strains were considered cagA positive when at least one of the reactions was positive.

For detection of ureA, genomic DNAs of the bacteria and from the tissue samples were amplified by use of a set of synthetic oligonucleotides primers, as described by Clayton et al. (4).

Histologic study. Biopsy samples of the gastric and esophageal mucosae obtained by endoscopy were fixed in 10% formalin and embedded in paraffin, and 5-µm-thick histologic sections were stained with hematoxylin-eosin for histologic analysis. The samples of the gastric mucosae were also stained with carbolfuchsin for H. pylori detection. The slides were examined by two independent pathologists who were not aware of their origins.

The corpus mucosae were analyzed for mononuclear and polymorphonuclear cells, which were scored as follows according to the revised Sydney system (6): none (score, 0), mild (score, 1), moderate (score, 2), or marked (score, 3). The numerical scores were derived by summing the single scores for mononuclear and polymorphonuclear cell infiltration (scores from 0 to 6).

Histologic alterations of the esophageal mucosa such as neutrophil and eosinophil infiltration, increased epithelial thickness, elongation of papillae, erosion, or ulceration were indicative of GERD.

Statistical analysis. Data were analyzed with the SPSS statistical software package (version 10.0; SPSS Inc., Chicago, Ill.).

Differences in the sensitivity of culture between the groups were evaluated by the two-tailed Fisher exact test.

Variables such as gender (male or female), mean age, H. pylori infection status (negative or positive), cagA status (negative or positive), inflammatory intensity, and the antral and oxyntic gastritis activities (scored as defined above) were evaluated. The association of each variable with GERD (the dependent variable) was tested by univariate analysis. All variables with P values of 0.25 or less were included in the full model of logistic regression, and variables with P values <0.05 were retained in the model. The odds ratio (OR) and the 95% confidence interval (CI) were used as estimates of the risk.

All patients were included in the first analysis, irrespective of their H. pylori infection status. In a second analysis, in order to better evaluate the role of the infection with a cagA-positive strain, only H. pylori-positive patients were studied.

Top Abstract Introduction Materials and Methods Results Discussion References

 
Of the 281 patients, 191 (68.0%; 75 men and 116 women; mean age, 44.8 ± 15.4 years; age range, 18 to 88 years) were H. pylori positive and 90 (32.2%; 42 men and 48 women; mean age, 45.3 ± 14.6 years; age range, 18 to 80 years) were H. pylori negative. Among the H. pylori-positive patients, the culture result was positive for 132 (92.9%) individuals in the control group and 45 (91.8%) individuals with GERD (P = 0.75).

Ninety-three patients fulfilled the criteria for GERD (Table 1). Among these patients, 84 (90.3%) presented with mild (n = 59) or moderate (n = 25) esophagitis and 9 (9.7%) presented with severe esophagitis. Among the individuals in the last group, Barrett's esophagus was seen in four patients.

View this table: [in this window] [in a new window]

TABLE 1. Relationship between GERD and variables related to the patients studieda

In the univariate analysis, GERD was associated with H. pylori infection, the degree of oxyntic gastritis, the mean age of the patients, and the patient's gender (Table 1). In the multivariate analysis, only the age of the patients and the degree of oxyntic gastritis remained associated with GERD (Table 2). Similar to the multivariate analysis, when the patients infected with cagA-positive strains were excluded, the prevalence of H. pylori infection with a cagA-negative strain was not significantly different (P = 0.6) between GERD patients (48.8%) and the controls (43.6%).

View this table: [in this window] [in a new window]

TABLE 2. Results of multivariate analysis with variables associated with GERD in H. pylori-positive and -negative patients

The cagA status was investigated in 178 H. pylori-positive patients, and cagA was identified in 11 of 45 (24.4%) strains or tissue specimens from patients with GERD and in 89 of 133 (66.9%) strains or tissue specimens from patients without the disease (P < 0.001). Compared to infection with cagA-negative strains, infection with a cagA-positive H. pylori strain was associated with a more intense gastritis (P = 0.001).

The univariate analysis showed that GERD was not associated with gender (P = 0.61). On the other hand, it was negatively associated with cagA-positive strains and the degree of the oxyntic gastritis and was positively associated with the age of the patients (Table 3).

View this table: [in this window] [in a new window]

TABLE 3. Relationship between GERD and variables related to the H. pylori-positive patients studieda

When the regression model was applied (Table 4), cagA status (OR = 0.16; 95% CI = 0.06 to 0.40; P < 0.001), gastritis of the corpus (OR = 0.69; 95% CI = 0.48 to 0.99; P = 0.048), and age (OR = 1.04; 95% CI = 1.01 to 1.07; P = 0.009) remained associated with GERD.

View this table: [in this window] [in a new window]

TABLE 4. Results of multivariate analysis with variables associated with GERD in patients infected by H. pylori

Top Abstract Introduction Materials and Methods Results Discussion References

 
Gastroesophageal reflux disease is a common disorder characterized by abnormal exposure of the esophageal mucosa to the acid gastric content. In developed countries, while the rates of GERD and carcinoma of the distal esophagus and proximal stomach have risen progressively, the rates of duodenal ulcer and distal gastric adenocarcinoma have decreased in parallel with the decrease in the rates of H. pylori infection (7).

Recently, several studies have evaluated the association between H. pylori infection and GERD. Some of them (13, 25, 27, 29) observed a protective effect of H. pylori infection against GERD, whereas this association was not seen in others (17, 26). These contradictory results could be due to bias, inconsistent tests for the diagnosis of H. pylori infection, or confounding factors. Points that strengthen the results of this study include the prospective study design, the large series of patients and controls, the accurate selection of controls, the adjustment for confounding factors, and the more accurate diagnosis of H. pylori infection. Since biopsy specimens may be false negative due to the patchy distribution of H. pylori in the stomach, we used four tests to improve the accuracy of the diagnosis of infection. Also, as has been recommended, in this study a result was considered truly positive only when the culture result was positive or the results of at least two other tests were positive, and a result was considered truly negative when the results of all tests were negative (16).

In the present study, although the prevalence of infection was lower in patients with GERD than in those without GERD, after adjustment for confounding factors, the disease remained associated only with age, being slightly more frequent in older subjects and in those with a less intense oxyntic gastritis. However, since in the univariate analysis H. pylori infection status and the degree of oxyntic gastritis were both negatively associated with GERD, the lack of association between H. pylori infection and GERD in the multivariate analysis may be due to colinearity between these two covariates, also suggesting an overlap between groups of patients colonized with H. pylori strains that provoke or that do not provoke more intense gastritis. In fact, when the patients were stratified by the cagA status of the H. pylori strain, infection with a cagA-positive bacterium itself was independently and inversely associated with GERD. Furthermore, we also demonstrated that more severe corpus gastritis independently protects against GERD.

Previous studies have demonstrated that carriage of cagA-positive strains was inversely related to the severity of the reflux disease, indicating that carriage of cagA-positive strains has a protective role against esophageal complications of acid reflux such as Barrett's esophagus and Barrett's esophagus complicated by dysplasia or carcinoma (3, 10, 25). Our results, in agreement with those of a recent study (26), extend these findings and show that not only patients with more severe lesions but also those without complications may be protected by infection with cagA-positive strains.

Several possible explanations justify the protective effect of infection with cagA-positive H. pylori strains against GERD. cagA is considered a marker of the presence of the cag PAI in the H. pylori genome. The products of the cag PAI genes are associated with increased levels of production of interleukin-8 and more severe gastric lesions (5). Indeed, in the present study we observed that cagA-positive strains were associated with higher inflammation scores for the oxyntic mucosa. When the variables were analyzed in a logistic regression model, the degree of corpus gastritis as well as cagA status remained inversely associated with GERD. Gastritis of the corpus is associated with reduced gastric acid output, which in turn may reduce the degree of reflux esophagitis. Acid is a crucial cause of the damage to the esophageal mucosa. It may act in several ways. Besides the direct injury, it activates pepsin in the refluxate, and the lesions caused by acid and pepsin together are more severe than those associated only with acid. Acid also promotes the formation of conjugated bile salts of duodenogastroesophageal reflux, which are more undissociated and membrane permeable (8).

Although the protective role linked to infection with a cagA-positive H. pylori strain may be explained by the lower gastric acid output due to the more intense gastric lesions induced by these strains, a direct effect of the more virulent strains may not be ruled out. Thus, one may hypothesize that there is a bacterial product that acts, for example, in the prevention of lower esophageal sphincter relaxation.

Our results also showed that cagA status alone is neither essential nor sufficient in offering protection against GERD. Additional protective factors associated or not associated with cagA status may be considered. Among these, the genetics of the host may be a candidate. In a recent study, Figueiredo et al. (C. Figueiredo, J. C. Machado, R. Seruca, C. Caldas, S. Sousa, R. Carvalho, W. G. Quint, L. van Doorn, F. Carneiro, and M. Sobrinho-Simoes, XIVth Int. Workshop on Gastroduodenal Pathol. H. pylori, Strasbourg, France, abstr. 3/02, p. A13, 2001) have demonstrated that virulence markers of H. pylori strains such as cagA and the interleukin-1 gene polymorphism associated with high levels of interleukin-1ß activity have a synergistic effect in increasing the risk for atrophic gastritis and distal gastric carcinoma. Carriers of these polymorphic genes may be protected against GERD, even though they are at increased risk for distal gastric carcinoma.

In conclusion, we have provided evidence supporting the independent protective roles of cagA-positive H. pylori strains and the degree of corpus gastritis against GERD. Thus, some protective factor(s) linked to cagA-positive H. pylori strains other than gastritis should be evaluated, as should a possible host factor(s) linked to a more intense inflammatory response in the oxyntic mucosa.

 
This work was supported by FAPEMIG, CNPq, and FINEP/Brazil.

 
* Corresponding author. Mailing address: Faculdade de Medicina, UFMG, Av. Alfredo Balena, 190, sala 4026, 30130-100, Belo Horizonte, Brazil. Phone and fax: (55-31) 32742767. E-mail: dqueiroz{at}medicina.ufmg.br.

Top Abstract Introduction Materials and Methods Results Discussion References

 

1
1. Blaser, M. J., G. I. Pérez-Pérez, H. Kleanthous, T. L. Cover, R. M. Peek, Jr., P. H. Chyou, G. N. Stemmermann, and A. I. Nomura. 1995. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res. 5:2111-2115.
2
2. Censini, S., C. Lange, Z. Xiang, J. E. Crabtree, P. Ghiara, M. Borodovsky, R. Rappuoli, and A. Covacci. 1996. cagA, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc. Natl. Acad. Sci. USA 93:14648-14653.[Abstract/Free Full Text]
3
3. Chow, W. H., M. J. Blaser, W. J. Blot, M. D. Gammon, T. L. Vaughan, H. A. Risch, G. I. Pérez-Pérez, J. B. Schoenberg, J. L. Stanford, H. Rotterdam, A. B. West, and J. F. Fraumeni, Jr. 1998. An inverse relation between cagA⁺ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res. 58:588-590.[Abstract/Free Full Text]
4
4. Clayton, C. L., H. Kleanthous, P. J. Coates, D. D. Morgan, and S. Tabaqchali. 1992. Sensitive detection of Helicobacter pylori by using polymerase chain reaction. J. Clin. Microbiol. 30:192-200.[Abstract/Free Full Text]
5
5. Crabtree, J. E., A. Covacci, and S. M. Farmery. 1995. Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J. Clin. Pathol. 48:41-45.[Abstract/Free Full Text]
6
6. Dixon, M. F., R. M. Genta, J. H. Yardley, and P. Correa. 1996. Classification and grading of gastritis—the updated Sydney system. Am. J. Surg. Pathol. 20:1161-1181.[CrossRef][Medline]
7
7. El-Serag, H. B., and A. Sonnenberg. 1998. Opposing time trends of peptic ulcer and reflux disease. Gut 43:327-333.[Abstract/Free Full Text]
8
8. El-Serag, H. B., A. Sonnenberg, M. M. Jamal, J. M. Inadomi, L. A. Crooks, and R. M. Feddersen. 1999. Corpus gastritis is protective against reflux oesophagitis. Gut 45:181-185.[Abstract/Free Full Text]
9
9. Fallone, C. A., A. N. Barkun, G. Friedman, S. Mayrand, V. Loo, and R. Beech. 2000. Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am. J. Gastroenterol. 95:914-920.[CrossRef][Medline]
10
10. Fallone, C. A., A. N. Barkun, U. M. Gottke, L. M. Best, V. G. Loo, S. V. van Zanten, T. Nguyen, A. Lowe, T. Fainsilber, K. Kouri, and R. Beech. 2000. Association of Helicobacter pylori genotypes with gastroesophageal reflux disease and other upper gastrointestinal diseases. Am. J. Gastroenterol. 95:659-669.[CrossRef][Medline]
11
11. Feldman, M., B. Cryer, D. Sammer, E. Lee, and S. J. Spechler. 1999. Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. Am. J. Physiol. 277:G1159-G1164.[Abstract/Free Full Text]
12
12. Kelly, S. M., M. C. L. Pitcher, S. M. Farmery, and G. R. Gibson. 1994. Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom. Gastroenterology 107:1671-1674.[Medline]
13
13. Koike, T., S. Ohara, H. Sekine, K. Iijima, Y. Abe, K. Kato, T. Toyota, and T. Shimosegawa. 2001. Helicobacter pylori infection prevents erosive reflux oesophagitis by decreasing gastric acid secretion. Gut 49:330-334.[Abstract/Free Full Text]
14
14. Labenz, J., A. L. Blum, E. Bayerdorffer, A. Meining, M. Stolte, and G. Borsch. 1997. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 112:1442-1447.[CrossRef][Medline]
15
15. Manes, G., S. Mosca, M. Laccetti, M. Lioniello, and A. Balzano. 1999. Helicobacter pylori infection, pattern of gastritis, and symptoms in erosive and nonerosive gastroesophageal reflux disease. Scand. J. Gastroenterol. 34:658-662.[CrossRef][Medline]
16
16. Mégraud, F. 1996. Advantages and disadvantages of current diagnostic tests for the detection of Helicobacter pylori. Scand. J. Gastroenterol. 215:57-62.
17
17. Mégraud, F., and H. Lamouliatte. 1992. Helicobacter pylori and duodenal ulcer. Dig. Dis. Sci. 37:769-772.[CrossRef][Medline]
18
18. Newton, M., R. Bryan, W. R. Burnham, and M. A. Kamm. 1997. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus. Gut 40:9-13.[Abstract/Free Full Text]
19
19. Parsonnet, J., G. D. Friedman, D. P. Vandersteen, Y. Chang, J. H. Vogelman, N. Orentreich, and R. K. Sibley. 1991. Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med. 325:1127-1131.[Abstract]
20
20. Peek, R. M., Jr., G. G. Miller, K. Tham, G. I. Pérez-Pérez, T. L. Cover, J. C. Atherton, G. D. Dunn, and M. J. Blaser. 1995. Detection of Helicobacter pylori gene expression in human gastric mucosa. J. Clin. Microbiol. 33:28-32.[Abstract]
21
21. Queiroz, D. M. M., E. N. Mendes, and G. A. Rocha. 1987. Indicator medium for isolation of Campylobacter pylori. J. Clin. Microbiol. 25:2378-2379.[Abstract/Free Full Text]
22
22. Queiroz, D. M. M., E. N. Mendes, G. A. Rocha, A. M. R. Oliveira, C. A. Oliveira, P. P. Magalhães, S. B. Moura, M. M. D. A. Cabral, and A. M. M. F. Nogueira. 1998. cagA-positive Helicobacter pylori and risk for developing gastric carcinoma in Brazil. Int. J. Cancer 78:135-139.[CrossRef][Medline]
23
23. Tefera, S., J. G. Hatlebakk, and A. Berstad. 1999. The effect of Helicobacter pylori eradication on gastroesophageal reflux. Aliment. Pharmacol. Ther. 13:915-920.[CrossRef][Medline]
24
24. Vakil, N., B. Hahn, and D. McSorley. 2000. Recurrent symptoms and gastroesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment. Pharmacol. Ther. 14:45-51.[CrossRef][Medline]
25
25. Vicari, J. J., R. M. Peek, G. W. Falk, J. R. Goldblum, K. A. Easley, J. Schnell, G. I. Pérez-Pérez, A. S. Halter, T. W. Rice, M. J. Blaser, and E. R. Joel. 1998. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 115:50-57.[CrossRef][Medline]
26
26. Warburton-Timms, V. J., A. Charlett, R. M. Valori, J. S. Uff, N. A. Shepherd, H. Barr, and C. A. M. McNulty. 2001. The significance of cagA⁺ Helicobacter pylori in reflux oesophagitis. Gut 49:341-346.[Abstract/Free Full Text]
27
27. Werdmuller, B. F. M., and R. J. L. F. Loffeld. 1997. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis. Dig. Dis. Sci. 42:103-105.[CrossRef][Medline]
28
28. Wotherspoon, A., O. Ortiz-Hidalgo, M. Falzon, and P. G. Isaacson. 1991. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 338:1175-1176.[CrossRef][Medline]
29
29. Wu, J. C. Y., J. J. Y. Sung, E. K. W. Ng, M. Y. Y. Go, W. B. Chan, F. K. L. Chan, W. K. Leung, C. L. Choi, and S. C. S. Chung. 1999. Prevalence and distribution of Helicobacter pylori in gastroesophageal reflux disease: a study from the east. Am. J. Gastroenterol. 94:1790-1794.[CrossRef][Medline]

---

Journal of Clinical Microbiology, August 2002, p. 2849-2853, Vol. 40, No. 8
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.8.2849-2853.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Farinati, F., Cardin, R., Russo, V. M., Busatto, G., Franco, M., Falda, A., Mescoli, C., Rugge, M. (2004). Differential Effects of Helicobacter pylori Eradication on Oxidative DNA Damage at the Gastroesophageal Junction and at the Gastric Antrum. Cancer Epidemiol. Biomarkers Prev. 13: 1722-1728 [Abstract] [Full Text]  
• Blaser, M. J. (2002). Polymorphic Bacteria Persisting in Polymorphic Hosts: Assessing Helicobacter pylori-Related Risks for Gastric Cancer. JNCI J Natl Cancer Inst 94: 1662-1663 [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Queiroz, D. M. M. Articles by Nogueira, A. M. M. F. Search for Related Content PubMed PubMed Citation Articles by Queiroz, D. M. M. Articles by Nogueira, A. M. M. F.